We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Janssen Loses Patent Dispute Over Remicade, Plans to Continue Fight
Janssen Loses Patent Dispute Over Remicade, Plans to Continue Fight
A federal judge rendered Janssen’s composition patent for Remicade invalid, marking a loss for the company engaged in ongoing efforts to block biosimilar competition.